Inventor · disambiguated record
Sreekantha Ratna Kumar
Also filed as: KUMAR SREEKANTHA R · KUMAR SREEKANTHA RATNA
33 granted patents·6 pending applications·104 citations·filing 2013–2023
96Inventor score
Files withBRISTOL MYERS SQUIBB CO39
Top patents by PatentIndex Score
39 records- 0196USRE49880E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 26, 2024·2 cites·20 claims
- 0296US10544143B24-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·10 cites·27 claims
- 0395US11053244B14-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 6, 2021·6 cites·7 claims
- 0495US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0593US10730877B24-Azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 4, 2020·6 cites·13 claims
- 0691USRE49893E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 2, 2024·1 cites·17 claims
- 0791US11180474B2Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 23, 2021·6 cites·14 claims
- 0891US10071079B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·6 cites·20 claims
- 0989US10478424B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 19, 2019·5 cites·17 claims
- 1088US8987311B2Triazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 24, 2015·14 cites·16 claims
- 1187US11299501B2Diazaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 12, 2022·3 cites·8 claims
- 1286US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 1386US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1485US11427580B26-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 30, 2022·3 cites·9 claims
- 1585US11420958B2Aryl and heteroaryl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 1685US11420973B2Amide substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 1785US9862715B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 9, 2018·5 cites·2 claims
- 1881USRE49931E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 23, 2024·0 cites·17 claims
- 1981US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 2081US9169252B2Heteroaryl substituted nicotinamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 27, 2015·5 cites·9 claims
- 2180US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 2278US9242975B2Heterocyclic-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·4 cites·13 claims
- 2375US11672780B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 13, 2023·0 cites·13 claims
- 2473US11820768B24-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 21, 2023·0 cites·10 claims
- 2571US9242976B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·1 cites·7 claims
- 2668US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 2767US11912703B26-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Feb 27, 2024·0 cites·8 claims
- 2863US2025066344A1Benzothiazole, benzoisoxazole, and benzodioxole analogs as rxfp1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2958US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 3058US10227340B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 12, 2019·0 cites·8 claims
- 3158US2025011288A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3258US2025221966A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3354US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 3452US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3550US12187723B2Substituted benzimidazolone compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 7, 2025·0 cites·12 claims
- 3648US12448395B2Substituted bicyclic heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 21, 2025·0 cites·13 claims
- 3748US2023117470A1Substituted pyrazole compounds as toll receptor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3846US11878975B2Substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 23, 2024·0 cites·14 claims
- 3935US10618903B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Sreekantha Ratna Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →